We wanted take time to recognize and express our enduring gratitude to Dr. Ken McClain and the Histiocytosis Program at the Texas Children's Cancer Center for really making a difference in the fight against histiocytosis.
The Histiocytosis Program at the Texas Children's Cancer Center, is associated with Texas Children's Hospital, the largest pediatric hospital in the United States, and serves as the pediatric program of The Dan L. Duncan Cancer Center, an NCI-designated cancer center at the Baylor College of Medicine
The Histiocytosis Program Director, Kenneth L. McClain, M.D. Ph.D., is the past president of the Histiocyte Society and has been treating patients with histiocytic disorders for over twenty years. He sees over 100 new LCH and HLH patients per year, and has over 400 active patients in the clinic. Dr. McClain is one of only a few physicians in the world researching a cure for children with histiocytosis.
The Histiocytosis Research Laboratory, through the dramatic increase in the number of patients, has been able to develop and expand clinical trials of innovative therapies and leads the world in research of LCH, HLH, JXG, RDD, and ECD. The clinical experience developed, coupled with the basic research studies involving with rare biopsy and other tissue samples, provides the unique opportunity to establish clinical and biologic correlations that no other center in the world can.
The Histiocytosis Program needs additional support support to expand its ongoing research efforts and to pursue additional state-of-the-art investigations that will lead to discoveries which will expedite development of more effective and innovative therapies for histiocytic disorders.
Please contact Mike Golding or Don Johnson if you are interested in learning more about how you can help Dr. McClain in the fight against histiocytosis.
No comments:
Post a Comment